Dipeptidyl peptidase-IV in chronic heart failure with reduced ejection fraction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dipeptidyl peptidase-IV in chronic heart failure with reduced ejection fraction

Published:2017-08 Issue: Volume:241 Page:249-254
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Lourenço Patrícia,Silva Sérgio,Cunha Filipe,Pereira Joana,Ribeiro Ana,Silva Nuno,Guimarães João Tiago,Araújo José Paulo,Bettencourt Paulo

Funder

Norte Portugal Regional Operational Programme

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference50 articles.

1. Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV;Lambeir;Crit. Rev. Clin. Lab. Sci.,2003

2. Elevated plasma GLP-1 levels and enhanced expression of cardiac GLP-1 receptors as markers of left ventricular systolic dysfunction: a cross-sectional study;Hattori;BMJ Open,2013

3. Cardiovascular biology of the incretin system;Ussher;Endocr. Rev.,2012

4. Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials;Monami;Diabetes Obes. Metab.,2013

5. Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk: a meta-analysis of randomized clinical trials;Monami;Diabetes Obes. Metab.,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Re-evaluation of dipeptidyl peptidase-4 inhibitors in patients with heart failure and diabetes mellitus;Diabetes Research and Clinical Practice;2023-08

2. DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits;Military Medical Research;2022-08-20

3. Dipeptidyl Peptidase IV as a Muscle Myokine;Frontiers in Physiology;2020-03-03

4. Diabetic patients need higher furosemide doses;Journal of Cardiovascular Medicine;2020-01

5. Targeting the DPP-4-GLP-1 pathway improves exercise tolerance in heart failure patients: a systematic review and meta-analysis;BMC Cardiovascular Disorders;2019-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3